Surveillance After Orchidectomy for Stage I Testicular Seminoma
Author Information
Author(s): A. Horwich, N. Alsanjari, R.A'Hern, J. Nicholls, D.P. Dearnaley, C. Fisher
Primary Institution: Royal Marsden Hospital
Hypothesis
Can surveillance after orchidectomy effectively manage stage I testicular seminoma without the need for adjuvant radiotherapy?
Conclusion
Surveillance for stage I seminoma can be effective, with an 82% probability of remaining relapse-free at 5 years.
Supporting Evidence
- Seventeen patients relapsed during the study.
- The probability of remaining relapse-free at 5 years was 82%.
- No patients died of progressive germ cell tumors.
- Four of 42 patients with neither lymphatic nor vascular invasion recurred.
- Nine of 53 patients with either lymphatic or vascular invasion recurred.
- Three of eight cases with both lymphatic and vascular invasion recurred.
Takeaway
Doctors can watch some patients with early testicular cancer closely instead of giving them radiation, which can help avoid side effects.
Methodology
Patients underwent orchidectomy and were monitored for relapse over a median of 62 months, with detailed histopathological analysis of tumors.
Limitations
Identifying patients at risk of relapse is challenging, and the study suggests that surveillance should remain a research protocol.
Participant Demographics
Patients aged 22-74 years, median age 36 years.
Statistical Information
P-Value
0.05
Confidence Interval
74%-88%
Statistical Significance
p=0.05-trend
Want to read the original?
Access the complete publication on the publisher's website